UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 21, 2015
TRIVASCULAR TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in its Charter)
|
Delaware |
001-36419 |
87-0807313 |
|
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
3910 Brickway Blvd.
Santa Rosa, California
______________________
(Address of principal executive offices)
95403
___________________
(Zip Code)
(707) 543-8800
_____________________
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders.
TriVascular Technologies, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 21, 2015 (the “Annual Meeting”). Only stockholders of record as of the close of business on March 30, 2015, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 20,392,915 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:
Proposal 1: The election of two directors to hold office until the 2018 annual meeting of stockholders or until his respective successor is elected:
|
|
|
|
|
|
|
|
|
Nominee |
|
Votes For |
|
Votes Withheld |
|
Broker |
|
Christopher G. Chavez |
|
16,435,028 |
|
1,141,289 |
|
413,162 |
|
Jake R. Nunn |
|
16,427,969 |
|
1,148,348 |
|
413,162 |
Proposal 2: To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015:
|
|
|
|
|
|
|
Votes For |
|
Votes Against |
|
Abstentions |
|
17,984,480 |
|
2,590 |
|
2,409 |
As a routine proposal under applicable rules, no broker non-votes were recorded in connection with Proposal 2.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
TRIVASCULAR TECHNOLOGIES, INC. |
||
|
|
|
|
|
|
|
|
|
|
|
Dated: May 27, 2015 |
/s/ Michael R. Kramer |
|
|
|
|
Name: |
Michael R. Kramer |
|
|
|
Title: |
Chief Financial Officer |
|